Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 5.10% is 26% below its 5-year average of 6.90%, around the middle of its 5-year range (0.85%–12.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.29% below its 12-month average of 5.69%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.10%.
DEBT TO ASSETS RATIO
5.10%
DEBT TO ASSETS RATIO AVG TTM
5.69%
DEBT TO ASSETS RATIO AVG 3Y
6.91%
DEBT TO ASSETS RATIO AVG 5Y
6.90%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-10.29%
CURRENT VS 3Y AVG
-26.17%
CURRENT VS 5Y AVG
-26.02%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
+1690.60%
vs the sector median at left
Recursion Pharmaceuticals, Inc.
Market Cap
$2.13B
Debt to Assets Ratio
5.10%
TTM Avg
5.69%
3Y Avg
6.91%
5Y Avg
6.90%
Market Cap
$2.49B
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.74B
Debt to Assets Ratio
0.44%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.72B
Debt to Assets Ratio
0.59%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.01B
Debt to Assets Ratio
0.38%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$389.98M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Recursion Pharmaceuticals, Inc. (RXRX) | $2.13B | 5.10% | 5.69% | 6.91% | 6.90% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | 0.18% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 0.44% | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | 0.09% | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 0.59% | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | 0.38% | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $470.35M | 0.33% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $459.30M | 0.66% | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | 0.10% | N/A | N/A | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | 0.50% | N/A | N/A | N/A |
Debt/Assets
5.1%
Debt/Equity
0.07
Current Ratio
5.03
Interest Coverage
-358.1x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 5.10% |
| 2026-03-31 | 5.40% |
| 2025-12-31 | 5.29% |
| 2025-09-30 | 5.89% |
| 2025-06-30 | 6.76% |
| 2025-03-31 | 7.12% |
| 2024-12-31 | 7.49% |
| 2024-09-30 | 12.47% |
| 2024-06-30 | 11.58% |
| 2024-03-31 | 9.14% |
| 2023-12-31 | 7.75% |
| 2023-09-30 | 8.16% |
| 2023-06-30 | 7.93% |
| 2023-03-31 | 8.46% |
| 2022-12-31 | 7.27% |
| 2022-09-30 | 8.53% |
| 2022-06-30 | 7.98% |
| 2022-03-31 | 7.10% |
| 2021-12-31 | 1.88% |
| 2021-09-30 | 0.85% |
| 2021-06-30 | 2.22% |
| 2021-03-31 | 5.71% |
| 2020-12-31 | 5.25% |
